Astrocytoma: all 434 studies
Page 1 of 5. Open to participants first (79), then studies with results posted, then the rest; newest registration first within each.
- Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young AdultsNot yet recruitingNCT07891286Phase 2
- IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade AstrocytomasNot yet recruitingNCT07888647Phase 2
- A Multicenter Safety and Immunogenicity Window-of-opportunity Phase 1 Interventional Trial Assessing the Combination of IDH1 Vaccine (IDH1-vac) and Vorasidenib in Adult Patients With Recurrent IDH1R132H-mutant Astrocytoma, Grade 2 - 4 (iVOCAL)Not yet recruitingNCT07877415Phase 1
- Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II StudyNot yet recruitingNCT07832123Phase 2
- VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent GliomaRecruitingNCT07831369Phase 2
- Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®Not yet recruitingNCT07821112Phase 2
- Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT07733674Phase 1
- Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant GliomaNot yet recruitingNCT07712757Phase 3
- Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-BeingNot yet recruitingNCT07628647Not applicable
- Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:RecruitingNCT07608003
- First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 AstrocytomaRecruitingNCT07560865Phase 1
- Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade GliomasRecruitingNCT07544992Phase 1
- Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade GliomasRecruitingNCT07468136Phase 1/2
- Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1RecruitingNCT07462507Phase 2
- Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.RecruitingNCT07439172Phase 2
- Tuvusertib in Astrocytoma With ATRX MutationRecruitingNCT07417761Phase 2
- GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 AstrocytomaRecruitingNCT07301268Phase 2
- A Study of 177Lu-PSMA-617 in People With GliomasRecruitingNCT07223034Phase 1
- Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain CancerRecruitingNCT07215910Phase 3
- Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)RecruitingNCT07159607
- The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From BevacizumabRecruitingNCT07052877
- FearLess in NeuroOncologyRecruitingNCT06989086Not applicable
- Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) ProgressionRecruitingNCT06975332Not applicable
- Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational ApproachRecruitingNCT06915649
- Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade GliomaEnrolling by invitationNCT06896110Phase 1
- A Supportive Group Intervention for Caregivers to Patients Diagnosed With a GlioblastomaNot yet recruitingNCT06869577Not applicable
- Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaRecruitingNCT06860594Phase 1
- Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaRecruitingNCT06815029Phase 1
- Vorasidenib Maintenance for IDH Mutant AstrocytomaRecruitingNCT06809322Phase 3
- Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients With Brain Lesions.RecruitingNCT06797661Not applicable
- Study of How Safe and Effective Tarlatamab is in Brain CancersRecruitingNCT06776250Phase 2
- Extensive Resection of Malignant Brain Tumors Using Advanced Imaging TechniquesRecruitingNCT06623565Not applicable
- USPIO Enhanced MR Imaging in CNS Tumours (UMIC)RecruitingNCT06572475Not applicable
- Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent GlioblastomaRecruitingNCT06344130Phase 1
- Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK FusionRecruitingNCT06333899Early Phase 1
- The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)RecruitingNCT06283927
- The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent GlioblastomaRecruitingNCT06273176
- DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic AstrocytomaRecruitingNCT06264388Phase 2
- Ga-68 Prostate Specific Membrane Antigen PET/CT in GliomasNot yet recruitingNCT06241391Not applicable
- IDH1 and OCT4 in High Grade AstrocytomaRecruitingNCT06214689
- Study of Olutasidenib and Temozolomide in HGGRecruitingNCT06161974Phase 2
- The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)RecruitingNCT06118723
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
- Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFieldsNot yet recruitingNCT06017063Not applicable
- MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion AssessmentRecruitingNCT05957679Not applicable
- Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of AgeRecruitingNCT05956821Phase 1/2
- Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or AstrocytomaRecruitingNCT05879367Phase 1
- Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutantRecruitingNCT05843253Phase 2
- Targeted Pediatric High-Grade Glioma TherapyRecruitingNCT05839379
- Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing CraniotomyRecruitingNCT05789394Phase 1
- A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaRecruitingNCT05765812Phase 1/2
- A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent GliomaRecruitingNCT05698524Phase 1
- Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.RecruitingNCT05686798Phase 1
- Venous Thromboembolism Prevention in Outpatients With GliomaRecruitingNCT05683808Phase 2
- Hierarchical Diagnosis for Adult Diffuse Glioma Based on Deep LearningRecruitingNCT05624736
- Correlation Between Psychological Stress and Progression of Diffuse Astrocytoma Towards Secondary GliomaNot yet recruitingNCT05532969
- Evaluation of ex Vivo Drug Combination Optimization Platform in Recurrent High Grade Astrocytic GliomaRecruitingNCT05532397Not applicable
- Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse AstrocytomaNot yet recruitingNCT05518994Phase 2
- Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesRecruitingNCT05417594Phase 1/2
- All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant GliomaRecruitingNCT05345002Phase 2
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)RecruitingNCT05303519Phase 3
- PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmasRecruitingNCT05190172Not applicable
- Pediatric Low Grade Glioma - MEKinhibitor TRIal vs ChemotherapyRecruitingNCT05180825Phase 2
- Study of Pembrolizumab and M032 (NSC 733972)RecruitingNCT05084430Phase 1/2
- SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade GliomaRecruitingNCT04923126Phase 1/2
- Loupe-Based Intraoperative Fluorescence ImagingRecruitingNCT04780009
- Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncologyRecruitingNCT04648462
- Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) GlioblastomasRecruitingNCT04623931Phase 2
- Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsRecruitingNCT04541082Phase 1
- Serial MRI Scans During Radiation TherapyRecruitingNCT04188535Not applicable
- Implantable Microdevice In Primary Brain TumorsRecruitingNCT04135807Early Phase 1
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsRecruitingNCT03911388Phase 1
- MSC-DNX-2401 in Treating Patients With Recurrent High-Grade GliomaRecruitingNCT03896568Phase 1
- The SAFE-Trial: Awake Craniotomy Versus Surgery Under General Anesthesia for Glioblastoma Patients.RecruitingNCT03861299Not applicable
- HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBMRecruitingNCT03603405Phase 1/2
- HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBMRecruitingNCT03596086Phase 1/2
- Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOARecruitingNCT02800486Phase 2
- Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade GliomaRecruitingNCT01649830Phase 3
- Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AARecruitingNCT01269853Phase 1/2
- PARP Inhibition for Gliomas (PI-4G or π4g)TerminatedNCT05297864Phase 2Results posted
- Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsTerminatedNCT04985604Phase 2Results posted
- Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas SystemCompletedNCT04743310Phase 2Results posted
- Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent GlioblastomaActive, not recruitingNCT04729959Phase 2Results posted
- INCB7839 in Treating Children With Recurrent/Progressive High-Grade GliomasCompletedNCT04295759Phase 1Results posted
- Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGGTerminatedNCT03973918Phase 2Results posted
- FORWARD Optune and Adjuvant TMZ in Grade II/III AstrocytomaTerminatedNCT03906448Phase 2Results posted
- Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 MutationsActive, not recruitingNCT03581292Phase 2Results posted
- Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their CaregiversCompletedNCT03538587Not applicableResults posted
- Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant AstrocytomaCompletedNCT03450850Not applicableResults posted
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPGTerminatedNCT03330197Phase 1/2Results posted
- Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.CompletedNCT03224104Phase 1Results posted
- Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant GliomaCompletedNCT03072134Phase 1Results posted
- Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in ChildrenCompletedNCT03043391Phase 1Results posted
- TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade AstrocytomaCompletedNCT03032484Phase 2Results posted
- Protein Phosphatase 2A Inhibitor, in Recurrent GlioblastomaCompletedNCT03027388Phase 2Results posted
- Laser Interstitial Thermal Therapy and Lomustine in Treating Patients With Recurrent Glioblastoma or Anaplastic AstrocytomaTerminatedNCT03022578Phase 2Results posted
- Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and GlioblastomaTerminatedNCT02942264Phase 1/2Results posted
- A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)TerminatedNCT02924038Phase 1Results posted
- Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in ChildrenTerminatedNCT02885324Phase 2Results posted
- Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive GlioblastomaCompletedNCT02858895Phase 2Results posted